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Arthroscopic knee surgeryAbstract Background: The combined use of intra-articular (IA) or intravenous (IV) magnesium-
sulfate (mgso4) with femoral nerve block might be associated with additive effects on the duration
and quality of postoperative analgesia in arthroscopic knee surgery.
Patients and methods: This randomized controlled double-blind study included 90 patients.
Femoral nerve block was performed in all patients using 20 ml 0.25% bupivacaine before induction
of general anesthesia. At the end of surgery patients were randomly allocated into: Group-IA (intra-
articular 1 g MgSO4 in 20 ml), Group-IV (intravenous 1 g MgSO4 in 20 ml), and Group-P (20 ml
intra-articular and 20 ml intravenous normal saline). 20 ml normal saline was given IV in IA group
and IA in IV group. Visual analogue pain score (VAS) at rest, with movement, time to ﬁrst post-
operative rescue analgesia, total postoperative diclofenac consumption, and the number of meper-
idine rescue doses during the ﬁrst 24 h postoperatively were measured.
Results: Pain scores were comparable in the three groups at 2 and 4 h and were signiﬁcantly higher
in the control group at 6 h and over 24 h. Group IA had the lowest pain scores. Duration of anal-
gesia was signiﬁcantly higher [11.6 (4.5) h] in IA group compared to [7.5 (3.6) h] in IV group and
[5.2 (2.3) h] in control group (p< 0.01). Total Diclofenac over 24 h was signiﬁcantly lower in IA
group [73.8 (50.9) mg] versus [138.4 (51.6) mg] in IV group and [186.0 (43.9) mg] in the control
group (p< 0.01).
240 M. Abdulatif et al.Conclusion: The combined use of femoral nerve block with IA or IV MgSO4 is associated with sig-
niﬁcant reduction of the intensity and duration of postoperative pain and postoperative analgesic
requirements in patients undergoing arthroscopic knee surgery with the IA MgSO4 being superior
to IV route of administration.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Acute pain from anterior cruciate ligament (ACL) reconstruc-
tion surgery has three major components: tissue injury, noci-
ceptor sensitization, and activation of a central pathway
[1,2]. Good-quality postoperative analgesia is essential for
early rehabilitation after arthroscopic knee surgery [3]. Local
anesthetics [4,5], opioids [6], alpha-2 adrenoceptor agonists
[7,8], and magnesium sulfate MgSO4 [9,10] have all been tried
intra-articularly either as sole agents or in combination, to
provide effective postoperative analgesia [3]. However, there
is increasing evidence of a potential toxic effect of local anes-
thetic agents to chondrocytes within the articular cartilage
[11]. In contrast, several reports have conﬁrmed the safety of
intra-articular MgSO4 at the chondrocyte level [12,13].
Furthermore, intra-articular MgSO4 appears to have protec-
tive effects on chondrocytes when co-administered with local
anesthetics [12].
It has been reported that intra-operative intravenous
MgSO4 reduces analgesic requirements and improves post-
operative analgesia [14]. Although the majority of studies have
concluded that magnesium sulfate has a positive analgesic
effect, some have produced negative results [15]. The mecha-
nism underlying the analgesic effect of magnesium is unclear.
Magnesium acts as an antagonist at N-methyl-D-aspartate
(NMDA) type glutamate receptors [15]. Block of NMDA
receptors is known to inhibit the induction and maintenance
of central sensitization to nociceptive stimuli [15].
N-methyl-D-aspartate receptors are present in the peripheral
terminal of articular primary afferent ﬁbers and on cellular
elements within the knee joint [14].
Femoral nerve block provides a superior analgesic effect for
patients undergoing ACL reconstruction surgery than placebo
[2]. However, when applied alone, femoral nerve block does
not facilitate early recovery [2]. The outcome with continuous
femoral nerve block has been shown to be better than ‘‘single
shot’’ femoral nerve block (SFNB) and continuous epidural
anesthesia [16]. Nevertheless, continuous femoral nerve block
for postoperative analgesia induces a frequent rate of catheter
colonization [17]. The concomitant use of single-shot femoral
nerve block and intravenous or intra-articular adjuvants
appears to be a logical alternative to continuous catheter
techniques.
This study was designed to investigate the potential anal-
gesic effect of intra-articular or intravenous MgSO4 as adju-
vant to femoral nerve block in adult patients undergoing
arthroscopic ACL reconstruction under general anesthesia.
2. Patients and methods
Ninety patients with ASA physical statuses I and II aging from
18 to 60 years scheduled for arthroscopic ACL reconstructionwere enrolled in this randomized controlled double-blinded
study. The study was approved by the Institutional Ethics
Committee and written informed consent was obtained from
each patient and is registered in the Pan African Clinical
Trial Registry with an identiﬁcation number
(PACTR201503001053196). The study was conducted in the
Orthopedic Surgical Theatre in Cairo University Hospitals.
Online randomization program (http://www.randomizer.org/)
and the sealed envelope method were used to allocate patient
in the three study groups and to conceal this allocation.
Patients with hepatic, renal, cardiac, hematological, or res-
piratory impairment, diabetic patients, morbidly obese and
pregnant patients with history of neuropathy, myopathy and
neuromuscular diseases, patients with prior treatment with
corticosteroids, calcium channel blockers, and opioids and
patients with cognitive dysfunction that may interfere with
the patient ability to provide reliable information about their
postoperative pain all were excluded from the study.
No premedication was given to allow for reliable assess-
ment of the femoral nerve block. Standard monitoring was
applied. Femoral nerve block was performed using 20 ml bupi-
vacaine 0.25% before induction of general anesthesia. A
peripheral nerve stimulator (STIMUPLEX HNS12, B Braun,
Germany) was used to localize the femoral nerve. A 22-gauge,
5-cm Contiplex D fully insulated atraumatic needle
(B Braun, Germany), was used for bupivacaine injection.
Over a period of 30 min after injection of peri-neural bupiva-
caine and prior to induction of anesthesia, a blinded investiga-
tor assessed sensory block by testing the pinprick sensation
along the medial aspect of the leg. The sensory block was
graded as follows: grade 0, normal sharpness sensation (com-
pared with the contralateral side); grade I, reduced sharpness
or a non-sharp sensation (touch or pressure); and grade II,
unable to recognize pinprick sensation. For motor block
assessment, the patient’s knee was fully ﬂexed, and the patient
was then asked to extend it. The motor block was classiﬁed as
follows: grade 0, normal muscle power; grade I, motor weak-
ness; and grade II, complete motor paralysis [9]. At the end
of the 30 min assessment period, patients with inadequate
femoral nerve block were excluded from the study.
After adequate assessment of femoral nerve block, general
anesthesia was induced using fentanyl 2 lg/kg and propofol
2 mg/kg. An appropriately sized laryngeal mask airway
(LMA) was inserted and patients were allowed to breathe
spontaneously and the tidal volume was augmented with the
use of pressure support ventilation mode. Anesthesia was
maintained using isoﬂurane 2–3% end-tidal concentration in
oxygen adjusted to maintain the heart rate and mean arterial
blood pressure within ±10% of their baseline values. No other
analgesics were given intraoperatively.
At the conclusion of surgery, patients were randomized to
one of three equal groups (n= 30): Group-IA received 20 ml
intra-articular MgSO4 (10 ml 10% MgSO4 ‘‘1 g’’ diluted in
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Group-IV received Intravenous 20 ml MgSO4 (10 ml 10%
‘‘1 g’’ MgSO4 diluted in 10 ml normal saline) plus 20 ml IA
normal saline, and Group-P received 20 ml intra-articular
and 20 ml intravenous normal saline and served as the control
group. Intravenous medications were given over 10 min.
All patients were evaluated at scheduled post-operative fol-
low-up visits (2, 4, 6, 12, and 24 h) to assess and manage post-
operative pain and to record the study outcome measures over
24 h. The primary outcome measure of this study was the
intensity of postoperative pain at rest as assessed by 0–10
visual analogue pain score (VAS) where 0 = no pain and
10 = the worst unbearable pain. Secondary outcome measures
were dynamic visual analogue pain score with movement (knee
ﬂexion) and the period of bearable pain (the time interval from
completion of surgery until the ﬁrst rescue analgesic dose was
required). Diclofenac sodium (75 mg) was administered intra-
muscularly as an analgesic supplement if the recorded VAS
pain score was 3 or greater at rest. The maximum 24 h dose
of diclofenac was 200 mg. Persistent inadequate analgesia
despite a maximum diclofenac dose was managed by intramus-
cular meperidine 1 mg/kg. The total postoperative analgesic
doses of diclofenac and the number of meperidine rescue doses
required during the ﬁrst 24 h postoperatively were recorded.
Side-effects such as shivering, ﬂushing and reduction in heart
rate and arterial pressure by more than 15% of baseline values
were recorded and managed at the same time intervals as those
deﬁned for VAS assessment.
Serum magnesium levels were measured preoperatively and
one hour after I.V. or intra-articular MgSO4.
Based on the results of two previous studies [18,19] and
assuming a SD of 1 cm in pain score, we calculated a sample
size of 25 patients in each study group would be sufﬁcient to
detect a difference of 1 cm on the visual analogue score
(VAS) at an a threshold of 0.05 with power of 90%. We have
increased our sample size in each group to 30 patients to allow
for possible dropouts.
Statistical analysis was performed using the Statistical
Package for Social Sciences (SPSS). Patients’ demographics,
time to ﬁrst analgesic requirement, pain scores, and amount
of postoperative analgesics were compared using One-Way
Analysis of Variance (ANOVA) and Bonferroni post hoc test.
Repeated measure ANOVA was used to test for signiﬁcant dif-
ferences over time within each of the three study groups. Chi
square and Fisher Exact tests were used as appropriate for
comparison of categorical data. Continuous data are reported
as mean (SD). Nominal data are presented as numbers.
Differences were considered statistically signiﬁcant if a P of
<0.05 was obtained.
3. Results
Ninety patients fulﬁlled the study inclusion criteria. However,
81 patients completed the study. Details of allocation, random-
ization, exclusion, and ﬁnal number of patients analyzed in the
three study groups are provided in Fig. 1. Patients in the three
study groups were comparable with respect to demographic
data and duration of surgery (Table 1).
Resting visual analogue pain scores were comparable in the
three study groups at the 2 and 4 h assessment points. Starting
at the 6 h assessment point and over the 24 h observationperiod, pain scores were signiﬁcantly higher in the control pla-
cebo group compared to the intra-articular and intravenous
MgSO4 groups. Furthermore, at the 6, 12, and 24 h assessment
points, the use of intra-articular MgSO4 was associated with
lower pain scores compared to the intravenous route of admin-
istration. The lowest pain scores in the control placebo and
intravenous MgSO4 groups were reported at the 2 h assess-
ment point (Fig. 2). Dynamic pain scores adopted a similar
pattern at different assessment points in the three study groups
(Fig. 3).
The use of intra-articular and intravenous MgSO4 was
associated with signiﬁcant (p< 0.01) prolongation of the time
to ﬁrst request to postoperative rescue analgesic [11.6 (4.5) h]
and [7.5 (3.6) h] respectively as compared to [5.2 (2.3) h] in
the placebo group. The longest duration was observed with
the intra-articular MgSO4 route of administration. Intra-
articular and intravenous MgSO4 administration was
associated with signiﬁcant reduction in the total dose of
diclofenac over 24 h. The least diclofenac requirements were
encountered with the use of the intra-articular regimen
(Fig. 4). Seven patients in the control group required rescue
meperidine analgesia.
The postoperative heart rate and arterial blood pressure
changes had a similar pattern in the three study groups
(Figs. 5–7). At the 2 and 4 h postoperative assessment points,
heart rate and arterial blood pressure values were comparable.
At the 6, 12 and 24 h assessment points, heart rate and arterial
blood pressure were signiﬁcantly higher (but within normal
limits) in the control group compared to the other two inter-
vention groups. Furthermore, at the 6, 12 and 24 h assessment
points in the control group, heart rate and arterial blood pres-
sure were signiﬁcantly higher compared to the other assess-
ment points.
There were no episodes of hypotension or bradycardia in
any patient in the three study groups. Flushing was reported
in 15 patients in the intravenous MgSO4 group. In contrast,
intra-articular MgSO4 and normal saline were not associated
with ﬂushing. Postoperative shivering was observed in 12
and 10 patients in the intra-articular and control placebo
groups, respectively. None of the patients included in the intra-
venous MgSO4 group developed postoperative shivering.
Preoperative serum magnesium levels were comparable in
the three study groups. Intra-articular and intravenous admin-
istration of magnesium was not associated with signiﬁcant
increase in serum magnesium levels compared to the control
placebo group. There was an expected trend to higher serum
magnesium level in the intravenous magnesium group.
However, this increase did not reach statistical signiﬁcance
(Table 2).
4. Discussion
The Main ﬁnding of this study is that, compared to a single
injection femoral nerve block, the combined use of nerve block
with equal doses of intra-articular or intravenous MgSO4 in
patients undergoing arthroscopic anterior cruciate ligament
reconstruction is associated with signiﬁcant improvement in
the intensity of postoperative pain, extension of the duration
of postoperative analgesia, and reduced postoperative anal-
gesic requirements. The postoperative analgesic effects of
intra-articular MgSO4 were superior to the intravenous route
Figure 1 CONSORT ﬂow diagram of the three study groups.
Figure 2 Visual analogue pain score at rest. Values are means
and error bars represent the standard deviations.
Table 1 Demographic characteristics of patients and duration
of surgery. Values are means (SD) or numbers.
Placebo
(n= 27)
Intra-articular
(n= 28)
Intravenous
(n= 26)
P
value
Age (y) 35.0 (10.4) 34.6 (9.3) 34.4 (8.3) 0.97
Weight (kg) 78.7 (11.7) 77.9 (10.7) 78.0 (11.1) 0.96
Sex (M/F) 20/7 17/11 20/6 0.61
ASA I/ASA II 18/7 17/8 19/6 0.82
Duration of
surgery (min)
96.9 (9.5) 95.4 (10.8) 96.4 (7.5) 0.86
242 M. Abdulatif et al.of administration. The least postoperative analgesic require-
ments were encountered with the use of combined femoral
nerve block and intra-articular MgSO4.
This is the ﬁrst report of the use of this multimodal postop-
erative analgesic regimen targeting pain pathway at the level of
the main sensory nerve supply to the anterior aspect of the
knee joint and at the peripheral receptors in the synovial mem-
brane. Our results with intra-articular MgSO4 are generally in
agreement with previously published studies investigating a
similar concept. Bondok and Abdel-Hady [18] studied the
effect of intra-articular 500 mg MgSO4 for postoperativeanalgesia in arthroscopic knee surgery. They reported signiﬁ-
cantly lower pain scores in the MgSO4 group compared to
the control group at 1, 2, 6 and 8 h after the end surgery.
Radwan et al. [1] reported that intra-articular MgSO4 provided
postoperative analgesia after total knee arthroplasty and
arthroscopic knee surgery comparable with that produced with
intra-articular bupivacaine though signiﬁcantly longer in dura-
tion. El-Sharnouby et al. [19], El-Bahnasawe et al. [20] and
Hemida [21] in three separate studies reported more effective
Figure 3 Dynamic visual analogue pain score. Values are means
and error bars represent the standard deviations.
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articular magnesium and bupivacaine compared to the isolated
use of either medication. Intra-articular administration of
MgSO4 or morphine, with bupivacaine, had comparable anal-
gesic effects [9,22]. However, the MgSO4–morphine combina-
tion provided more effective postoperative analgesia than
either drug alone. [22] The results obtained with the combined
use of intra-articular MgSO4 and bupivacaine were reproduced
with the use of ropivacaine [14], and Levobupivacaine. [23].
Our study demonstrated a relatively different postoperative
pain proﬁle; the resting and the dynamic visual analogue pain
scores were comparable in the three study groups at 2 and 4 h
assessment points. Starting at 6 h assessment point and over
the 24 h observation period, pain scores were signiﬁcantly
higher in the control group compared to other two groups.
The values for the resting and dynamic visual analogue pain
score at 2, 4 and 6 h assessment points were lower than the val-
ues reported by the above mentioned studies. Both observa-
tions could be related to the residual effect of the
intraoperative femoral nerve block.
Various factors have been implicated in the intensity of
pain and the effectiveness of intra-articular analgesia after
knee arthroscopy. These include preoperative pain scores
[24], duration of anesthesia [24], type of surgery [25], volume
injected [26,27], time of intra-articular injection in relation to
tourniquet deﬂation [27], and pain assessment at rest and
movement [28]. All these factors make the large number ofFigure 4 Total diclofenac requirements over 24 h. Values are
means and error bars represent the standard deviations.studies difﬁcult to compare [1]. Neuraxial block can affect
the pain scores in the early postoperative time. Therefore, in
the design of this study, we used general anesthesia to allow
for rapid recovery and reliable assessment of the postoperative
analgesia proﬁle.
The peripheral analgesic effects of MgSO4 were also
reported at the neuraxial and peri-neural levels. A recent
report by Ekmekci et al. [29] demonstrated that the addition
of 150 mg of MgSO4 to 20 ml to levobupivacaine 0.25% pro-
longed the sensory and motor block duration of femoral nerve
block and reduced rescue analgesic requirements in patients
undergoing ACL reconstruction. However, the addition of
magnesium delayed the time to ﬁrst mobilization. Similar
observation was reported with the combined use of MgSO4
and bupivacaine for interscalene brachial plexus block [30].
Two recent systematic reviews [31,32] concluded that
co-administration of intrathecal or epidural MgSO4 increases
the duration of neuraxial blocks. It is to be noted however that
the addition of intrathecal magnesium sulfate to spinal anes-
thesia is not desirable in patients undergoing knee arthroscopy
due to the extended duration of motor block and delayed time
to ambulation [33].
In contrast to the earlier reports of intra-articular MgSO4,
we have included a parallel intravenous administration group
using the same dose level of magnesium. The use of low dose
level of intravenous MgSO4 in the present study was associated
with potentiation of the postoperative analgesic effects of
femoral nerve block. However, intra-articular administration
was superior in this context. Similarly, postoperative intra-
venous MgSO4 infusion increased time to ﬁrst perception of
postoperative pain and rescue analgesic request without signif-
icant effect on the time to motor block resolution in lidocaine-
induced axillary brachial plexus block [34]. The effectiveness of
perioperative administration of intravenous MgSO4 as an
analgesic sparing regimen is considered to be a controversial
issue over the past few years. However, the most recent high
quality evidence derived from well conducted meta-analyses
and systematic reviews indicates that systemic administration
of MgSO4 reduces postoperative pain scores and opioid
consumption [35]. The authors concluded that intravenous
MgSO4 should be considered as a strategy to mitigate postop-
erative pain in surgical patients [36].Figure 5 Postoperative heart rate changes in the three study
groups. Values are means and error bars represent standard
deviations.
Table 2 Serum magnesium level (mEq/L). Values are means
(SD).
Placebo
(n= 27)
Intra-articular
(n= 28)
Intravenous
(n= 26)
P
value
Preoperative 2.1 (0.12) 2.0 (0.22) 2.1 (0.28) 0.35
Postoperative 2.1 (0.2) 2.1 (0.19) 2.4 (0.18) 0.16
Figure 7 Diastolic arterial blood pressure changes in the three
study groups. Values are means and error bars represent standard
deviations.
Figure 6 Systolic arterial blood pressure changes in the three
study groups. Values are means and error bars represent standard
deviations.
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levels were comparable in the three study groups. Intra-articu-
lar and intra-venous administration of magnesium was not
associated with signiﬁcant increase in serum magnesium levels
compared to the control placebo group. Trials reporting on
serum magnesium concentrations in patients receiving periop-
erative systemic magnesium are too heterogeneous and data
reporting was inconsistent to allow for a relationship between
the degree of hypo-magnesemia and pain intensity [37].
In the present study, the postoperative heart rate and arte-
rial blood pressure changes adopted a similar pattern in the
three study groups. Heart rate and arterial blood pressurevalues were comparable at the 2 and 4 h postoperative assess-
ment points. This is probably due to adequate postoperative
analgesia provided by the residual effect of femoral nerve
block. At the 6, 12 and 24 h assessment points, heart rate
and arterial blood pressure were signiﬁcantly higher (but
within normal limits) in the control group compared to the
other two intervention groups, suggesting an adequate anal-
gesic effect of both the intra-articular and intravenous magne-
sium sulfate. Furthermore, in the control group, heart rate and
arterial blood pressure at the 6, 12 and 24 h assessment points
were signiﬁcantly higher compared to the other assessment
points. Inadequate control of postoperative pain is associated
with increased levels of catecholamines [38].
Magnesium sulfate may induce hypotension by vasodilata-
tion, sympathetic blockade and inhibition of catecholamine
release [39]. However, no hypotensive episodes were observed
with the use of the relatively low dose of intravenous
MgSO4. These results are supported by a study of Ozcan
et al. [40] which used intravenous injection and infusion of
MgSO4 for patients undergoing thoracotomy.
Flushing was reported in 15 patients in the intravenous
magnesium group. In contrast, none of the patients in the
intra-articular magnesium or control placebo groups devel-
oped ﬂushing. A Cochrane systematic review reported that
ﬂushing is the most common side effect of intravenous
MgSO4 therapy in pre-eclamptic patients [41]. The vasodilator
effects of magnesium [42,43] could account for the high inci-
dence of ﬂushing with the use of the intravenous MgSO4.
Postoperative shivering was observed in 12 and 10 patients
in the intra-articular and control placebo groups, respectively.
None of the patients included in the intravenous MgSO4 group
developed postoperative shivering. Trame´r and Glynn [44]
tested the effect of a single preoperative intravenous bolus of
magnesium sulfate on postoperative pain and analgesic
requirements in patients undergoing outpatient inguinal hernia
and vein stripping surgery. They reported that postoperative
shivering was signiﬁcantly lower in magnesium group.
Lysakowski et al. [37] performed a comprehensive search for
randomized studies comparing the use of MgSO4 and placebo
in the surgical setting. They reported that MgSO4 decreases the
incidence of postoperative shivering.
The current study has some limitations: First, It is reported
that the use of ultrasonography during peripheral blocks
increases their effectiveness and decreases the amount of anes-
thetic required [45]. Ultrasound guidance for femoral nerve
block was not used in the current study. Second, it would have
been optimal to include two additional groups in the present
study, namely intra-articular and intravenous MgSO4 without
femoral nerve block. This could have elucidated the approxi-
mate share of magnesium in the overall duration of postoper-
ative analgesia. Lastly, we did not evaluate the preoperative
visual analogue score for our patients. Orthopedic patients
might have long standing pain states associated with central
sensitization. Assessment of preoperative pain scores could
have identiﬁed which patient has more potential to beneﬁt
from intra-articular MgSO4 administration.
In conclusion, the combined use of femoral nerve block
with equal doses of intra-articular or intravenous MgSO4 in
patients undergoing arthroscopic anterior cruciate ligament
reconstruction under general anesthesia is associated with sig-
niﬁcant improvement in the intensity of postoperative pain,
extension of the duration of postoperative analgesia, and
Intra-articular versus intravenous magnesium-sulfate as adjuvant to femoral nerve block 245reduced postoperative analgesic requirements. The postopera-
tive analgesic effects of intra-articular MgSO4 were superior to
the intravenous route of administration. The least postopera-
tive analgesic requirements were encountered with the use of
the intra-articular regimen.
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